[Mexican clinical experience in ocular anti-angiogenic therapy]. / Terapia antiangiogénica ocular: experiencia clínica en México.
Gac Med Mex
; 144(3): 245-53, 2008.
Article
em Es
| MEDLINE
| ID: mdl-18714594
Retinal pathological angiogenesis is the leading cause of visual loss in a wide variety of ocular diseases. Some of the examples include: Age-related macular degeneration, diabetic retinopathy and retinopathy associated with prematurity. These last two entities are, in addition, public health problems in developing countries. Recent physiopathological studies, have demonstrated that growth factors play a key role on angiogenesis. Anti-angiogenic therapy came about as an attempt to inhibit the action of growth factors over the process of pathological angiogenesis in order to preserve vision. The objective of this review is to describe Mexico's experience using this therapeutic approach.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neovascularização Retiniana
/
Neovascularização de Coroide
/
Inibidores da Angiogênese
Limite:
Humans
País/Região como assunto:
Mexico
Idioma:
Es
Revista:
Gac Med Mex
Ano de publicação:
2008
Tipo de documento:
Article
País de publicação:
México